HACKENSACK MERIDIAN HEALTH

Genetesis launched CardioFlux Membership, offering regular heart scans at CardioFlux Imaging Institutes to monitor myocardial fitness via CardioFlux Score. The program coincides with the opening of their first institute in Mason, Ohio, with plans for national expansion. The CardioFlux Score, assessable only via Genetesis' CardioFlux MCG device, analyzes 14 biomarkers of heart muscle electrical activity. Memberships are available in three plans, with results accessible via personalized online accounts. Genetesis aims to prevent heart disease through regular heart health monitoring.

CAN-2409, a viral immunotherapy, showed significant improvement in disease-free survival (DFS) in a phase 3 trial for high-risk localized prostate cancer patients, with a 14.5% relative improvement in DFS at 54 months and a 30% lower risk of disease progression or death. Patients treated with CAN-2409 also had a 40% lower chance of prostate cancer recurrence or death related to prostate cancer, and 80.4% pathological complete responses in two-year post-treatment biopsies.

Hackensack Meridian Health’s John Theurer Cancer Center presents latest hematologic oncology data at the 66th ASH Annual Meeting, highlighting new treatments for blood cancers.

AI is transforming healthcare, with 66% of clinicians recognizing its benefits and 38% already using it. AI aids in administrative tasks, diagnostic precision, and personalized patient care, potentially reducing burnout and improving outcomes. Privacy and security concerns are paramount, but AI's integration aims to enhance empathy and efficiency in healthcare delivery.

St. Baldrick's Foundation announces $1.2 million in infrastructure grants for pediatric cancer clinical trials, aiming to increase participation and offer new hope to children with cancer. Kathleen Ruddy, CEO, emphasizes support for communities impacted by hurricanes. Additionally, a research grant from 'Jack's Pack – We Still Have His Back' funds Dr. Roarke Kamber's Burkitt's Lymphoma research at UCSF. Grants awarded to various institutions across the U.S.

Becker's 2024 list highlights hospitals & health systems excelling in oncology, recognized for advanced clinical trials & research. Notable institutions include AdventHealth, Allina Health, Arkansas Children's, Atlantic Health System, Banner MD Anderson Cancer Center, Baylor Scott & White Health, Boston Medical Center, Brown University Health, Children's Health, Children's Hospital Colorado, Children’s Hospital Los Angeles, Children’s Hospital of Orange County, Children's Hospital of Philadelphia, Children's Nebraska, ChristianaCare, City of Hope Comprehensive Cancer Center, Cleveland Clinic, Connecticut Children’s, Covenant Health, Dana-Farber Cancer Institute, Dartmouth Health, DeTar Hospital Cancer Center, Duke Health, El Paso Children's Hospital, Emory Healthcare, Endeavor Health, Fred Hutchinson Cancer Center/UW Medicine, Geisinger, Hackensack Meridian Health, Huntsman Cancer Institute at the University of Utah, Inova, Jefferson Health, Johns Hopkins, Jupiter Medical Center, Keck Medicine of USC, Laredo Medical Center, Lehigh Valley Health Network, MUSC Health, MaineHealth, Massachusetts General Hospital, Mayo Clinic, MedStar, MemorialCare, Memorial Sloan Kettering Cancer Center, Michigan Medicine, Mount Sinai Health System, Nebraska Medicine, New York-Presbyterian Hospital-Columbia and Cornell, Northwestern Medicine, Novant Health, OSF HealthCare, OU Health, Ochsner Health, Ohio State University Comprehensive Cancer Center, Oregon Health & Science University Hospital, Orlando Health, Penn Medicine, Providence Alaska Medical Center, Providence Cancer Institute of Oregon, Providence South Division Cancer Institute, Queen's Health System, RWJBarnabas Health and Rutgers Cancer Institute, Renown Health, Rochester Regional Health, Roper St. Francis Healthcare, Roswell Park Comprehensive Cancer Center, Sanford Health, Sarasota Memorial Health Care System, Scripps Health, St. Jude Children's Research Hospital, Stanford Medicine, Stanford Medicine Children's Health, Sutter Health, Swedish Cancer Institute, Sylvester Comprehensive Cancer Center at University of Miami, Tampa General Hospital, Texas Children's Hospital, UC Davis Health, UCLA Health, UCSF Health, UK HealthCare, UNM Health System, UVA Health, UW Health, UMass Memorial Health, University of Alabama Birmingham Hospital, University of Chicago Medical Center, University of Colorado Cancer Center-UCHealth University of Colorado Hospital, University Hospitals, University of Iowa Health Care, University of Kansas Health System, University of Texas MD Anderson Cancer Center, University of Vermont Health Network, Vanderbilt University Medical Center, Virtua Health, WVU Cancer Institute, WellSpan Health, Yale New Haven Health.

Becker's honors healthcare CNOs for tackling nurse staffing shortages, managing budgets, and developing professional growth opportunities. CNOs oversee nursing departments, spearhead innovative patient care initiatives, and bring clinical expertise and executive leadership skills. The list is based on nominations and editorial research, with leaders presented in alphabetical order.

Brett Favre's Parkinson's diagnosis highlights potential links between collision sports and brain disease, with studies suggesting a single concussion can raise Parkinson's risk by over 55%. Favre, who played 20 NFL seasons, discussed his diagnosis during a Congressional hearing on welfare misuse, noting his belief in a 'breakthrough concussion drug'. Research indicates football increases Parkinson's risk by 61%, with repetitive head impacts linked to precursors of the disease. Neurologists stress the complexity of determining direct causation, citing multiple risk factors for Parkinson's.

Brett Favre's Parkinson's diagnosis highlights potential links between collision sports and brain disease, with studies suggesting concussions raise Parkinson's risk by over 55%. Favre, who played 20 NFL seasons, discussed his diagnosis during a Congress hearing on welfare misuse. Research indicates football increases Parkinson's odds by 61%, though factors like genetics and pesticides also play roles.